Nyxoah (CHIX:NYXHB) EBIT per Share : €-1.54 (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Nyxoah EBIT per Share?

Nyxoah's EBIT per Share for the three months ended in Mar. 2024 was €-0.40. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €-1.54.

During the past 3 years, the average EBIT per Share Growth Rate was -37.50% per year. During the past 5 years, the average EBIT per Share Growth Rate was -37.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Nyxoah's EBIT per Share or its related term are showing as below:

CHIX:NYXHb' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -50.5 Med: -38.65 Max: -8.5
Current: -37.5

During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Nyxoah was -8.50% per year. The lowest was -50.50% per year. And the median was -38.65% per year.

CHIX:NYXHb's 3-Year EBIT Growth Rate is ranked worse than
88.4% of 724 companies
in the Medical Devices & Instruments industry
Industry Median: 5.75 vs CHIX:NYXHb: -37.50

Nyxoah's EBIT for the three months ended in Mar. 2024 was €-11.44 Mil.

Nyxoah EBIT per Share Historical Data

The historical data trend for Nyxoah's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nyxoah EBIT per Share Chart

Nyxoah Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.40

-0.66

-1.02

-1.16

-1.59

Nyxoah Quarterly Data
	Dec17	Dec18	Jun19	Dec19	Mar20	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															-0.44	-0.41	-0.34	-0.39	-0.40

Nyxoah EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Nyxoah's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-44.44	/	27.968
=	-1.59

Nyxoah's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-11.437	/	28.676
=	-0.40

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.54

Nyxoah (CHIX:NYXHb) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Nyxoah EBIT per Share Related Terms

Thank you for viewing the detailed overview of Nyxoah's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Nyxoah (CHIX:NYXHB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nyxoah SA (CHIX:NYXHb) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

NYXH:USA 5YI:Germany NYXH:Belgium

Address

Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435

Website

https://www.nyxoah.com

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Nyxoah (CHIX:NYXHB) Headlines

No Headlines